These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31883101)

  • 21. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy in Pregnancy-Management Principles and Focus on Valproate.
    Błaszczyk B; Miziak B; Pluta R; Czuczwar SJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epilepsy and pregnancy. Factors associated with epileptic seizures during pregnancy.
    Jiménez M; Grau-López L; Ciurans J; García-Esperón C; Fumanal A; Barambio S; Chíes E; Codina M; Becerra JL
    Neurologia (Engl Ed); 2023 Mar; 38(2):106-113. PubMed ID: 36162697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
    Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
    Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
    Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
    J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
    Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
    Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L
    JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratogenicity of antiepileptic medications.
    Kluger BM; Meador KJ
    Semin Neurol; 2008 Jul; 28(3):328-35. PubMed ID: 18777479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best practice guidelines for the management of women with epilepsy.
    Crawford P
    Epilepsia; 2005; 46 Suppl 9():117-24. PubMed ID: 16302885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preconception care experiences of women with epilepsy on sodium valproate.
    Lawther L; Dolk H; Sinclair M; Morrow J
    Seizure; 2018 Jul; 59():82-89. PubMed ID: 29778017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing patterns of antiepileptic drug use in pregnant Australian women.
    Vajda FJ; Hollingworth S; Graham J; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
    Acta Neurol Scand; 2010 Feb; 121(2):89-93. PubMed ID: 20015108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.
    Toledo M; Mostacci B; Bosak M; Jedrzejzak J; Thomas RH; Salas-Puig J; Biraben A; Schmitz B
    J Neurol; 2021 Aug; 268(8):2735-2748. PubMed ID: 32239268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraception in patients with epilepsy.
    Bosak M; Cyranka K; Slowik A
    Ginekol Pol; 2019; 90(2):61-65. PubMed ID: 30860270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management issues for women with epilepsy: neural tube defects and folic acid supplementation.
    Yerby MS
    Neurology; 2003 Sep; 61(6 Suppl 2):S23-6. PubMed ID: 14504306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal Valproate Syndrome - Still a Problem Today!
    Wiedemann K; Stüber T; Rehn M; Frieauff E
    Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.
    Krauss GL; Brandt J; Campbell M; Plate C; Summerfield M
    Neurology; 1996 Jun; 46(6):1534-9. PubMed ID: 8649543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crossover from polytherapy to monotherapy in primary generalized epilepsy.
    Mattson RH; Cramer JA
    Am J Med; 1988 Jan; 84(1A):23-8. PubMed ID: 3146221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.